ask="6.45"
ask_size="400"
average_daily_volume="169268"
bid="N/A"
bid_size="N/A"
book_value="1.38"
change="+0.25"
change_from_200_day_moving_average="-0.76"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-3.00"
change_From_52_week_low="0.73"
change_in_percent="+4.90%"
close="5.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.61"
ebitda="-55.83M"
eps_estimate_current_year="-1.25"
eps_estimate_next_quarter="-0.28"
eps_estimate_next_year="-1.15"
ex_dividend_date="N/A"
float_shares="42788000"
high="5.40"
high_52_weeks="8.35"
last_trade_date="2/27/2017"
last_trade_price="5.35"
last_trade_size="6033"
last_trade_time="4:00pm"
low="5.10"
low_52_weeks="4.62"
market_capitalization="309.97M"
moving_average_200_day="6.11"
moving_average_50_day="5.42"
name="Sorrento Therapeutics
Inc."
notes="N/A"
one_year_target_price="24.33"
open="5.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.40%"
percent_change_from_50_day_moving_average="-1.24%"
percent_change_from_52_week_high="-35.93%"
percent_change_from_52_week_low="+15.80%"
previous_close="5.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.69"
price_per_sales="54.02"
revenue="5.47M"
shares_outstanding="57939000"
short_ratio="28.15"
stock_exchange="NCM"
symbol="SRNE"
volume="145549"
weeks_range_52="4.62 - 8.35"
